Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» depression
depression
Upcoming events – Axsome’s depression data and Eli Lilly’s IL-10 in lung cancer
EP Vantage
Fri, 12/13/19 - 11:02 am
Axsome Therapeutics
AXS-05
treatment-resistant depression
depression
Eli Lilly
pegilodecakin
lung cancer
China could quickly become the world’s largest antidepressant market, but hurdles remain
Marketwatch
Sun, 10/27/19 - 10:41 pm
China
antidepressants
depression
J&J depression drug Spravato gets half-hearted backing from VA doctors despite Trump's zeal
Fierce Pharma
Mon, 06/24/19 - 07:21 pm
JNJ
Spravato
Veteran's Affairs
Donald Trump
depression
J&J gains an enthusiastic endorsement from President Donald Trump for their big new drug Spravato
Endpoints
Thu, 06/13/19 - 10:00 am
Donald Trump
JNJ
Spravato
depression
veterans
Study Finds Ketamine Nasal Spray Effective For Treating Depression: What You Should Know
Forbes
Thu, 05/23/19 - 10:45 pm
depression
ketamine
esketamine
Spravato
JNJ
Janssen
Sanofi Joins Drugmakers' Bid to Treat Patients With Software
Yahoo/Bloomberg
Wed, 05/15/19 - 10:26 am
Sanofi
digital pharma
Happify Health
digital therapeutics
depression
multiple sclerosis
J&J prices ketamine-like depression treatment at $590-$885 for two doses
Reuters
Fri, 03/8/19 - 09:35 am
JNJ
Spravato
depression
drug pricing
esketamine
2 Biotech Stocks With Major Incoming Catalysts
Yahoo/Motley Fool
Thu, 03/7/19 - 09:52 am
Axsome Therapeutics
AXS-05
depression
Galapagos
filgotinib
Gilead Sciences
rheumatoid arthritis
[video+transcript]Why Alkermes' Depression Drug Stumbled, and How Illumina Plans to Profit From M&A
Motley Fool
Fri, 11/9/18 - 12:05 am
Alkermes
depression
ALSK-5461
opioids
Illumina
Pacific Biosciences
Ketamine is emerging as a popular treatment for depression. New research suggests the drug acts like an opioid
CNBC
Wed, 08/29/18 - 10:31 am
depression
ketamine
opioids
JNJ
Allergan
Diagnosing Depression By Blood Biomarkers: A Viable Approach?
Forbes
Tue, 07/31/18 - 10:21 am
depression
biomarkers
diagnostics
Nano Vision
Gut Microbes Associated With Obesity May Contribute to Depression and Anxiety
CP Wire
Mon, 06/18/18 - 11:15 am
microbiome
obesity
anxiety
depression
Gut Microbes Associated With Obesity May Contribute to Depression and Anxiety
Mon, 06/18/18 - 10:55 am
microbiome
depression
anxiety
On a roll, Sage grabs a $575M deal on limited Asian rights to SAGE-217 — a potential gamechanger in depression
Endpoints
Wed, 06/13/18 - 09:48 pm
SAGE Therapeutics
SAGE-217
Asia
Shionogi
depression
Neuronetics files for $86m IPO
Mass Device
Fri, 06/1/18 - 10:03 am
Neuronetics
devices
IPOs
depression
Can precision medicine do for depression what it’s done for cancer? It won’t be easy
Stat
Wed, 05/9/18 - 09:33 pm
depression
precision medicine
J&J’s Janssen touts Ph3 data for antidepressant nasal spray
Drug Delivery Business News
Mon, 05/7/18 - 09:37 am
JNJ
Janssen
esketamine
depression
JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study
CP Wire
Mon, 04/16/18 - 04:11 pm
JNJ
esketamine
depression
major depression
JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study
Mon, 04/16/18 - 04:10 pm
JNJ
esketamine
depression
major depression
FDA Rejects Alkermes NDA for Major Depressive Disorder Drug ALKS 5461
CP Wire
Mon, 04/2/18 - 09:01 am
Alkermes
FDA
depression
major depressive disorder
ALKS 5461
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »